Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging-Reference-Cited by-同舟云学术

Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging

Published:2020-04-27 Issue:9 Volume:100 Page:1252-1261
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Heijs Bram^ORCID,Holst-Bernal Stephanie,de Graaff Marieke A.,Briaire-de Bruijn Inge H.,Rodriguez-Girondo Mar,van de Sande Michiel A. J.,Wuhrer Manfred^ORCID,McDonnell Liam A.,Bovée Judith V. M. G.^ORCID

Funder

ZonMw

Liddy Shriver Sarcoma Initiative

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41374-020-0435-2.pdf

Reference51 articles.

1. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. Pathology and genetics of tumours of soft tissue and bone. In: World Health Organization classification of tumours. 4th ed. Lyon: IARC Press; 2013.

2. Lemeur M, Mattei J-C, Souteyrand P, Chagnaud C, Curvale G, Rochwerger A. Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up. Orthop Traumatol Surg Res. 2015;101:103–7.

3. Nishida Y, Tsukushi S, Nakashima H, Ishiguro N. Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall. Clin Orthop Relat Res. 2010;468:3041–6.

4. De Graaff MA, Yu JS, Beird HC, Ingram DR, Nguyen T, Juehui Liu J, et al. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation. Lab Invest. 2016;96:885–94.

5. Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res. 2001;7:3977–87.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mass Spectrometry Imaging of the Subchondral Bone in Osteoarthritis Reveals Tissue Remodeling of Extracellular Matrix Proteins that Precede Cartilage Loss;2024-08-05

2. Advancing rare cancer research by MALDI mass spectrometry imaging: Applications, challenges, and future perspectives in sarcoma;PROTEOMICS;2024-02-25

3. An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry;Scientific Reports;2024-01-04

4. Targeting Carbohydrates in Cancer – Analytical and Biotechnological Tools;Carbohydrate‐Based Therapeutics;2023-09-05

5. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) reveals potential lipid markers between infrapatellar fat pad biopsies of osteoarthritis and cartilage defect patients;Analytical and Bioanalytical Chemistry;2023-07-28